Doctolib Revenue, Valuation, Funding & Investors

Doctolib is valued at $4.2B as of April 2026. Doctolib revenue was $430M, as disclosed with its October 2026 round.

Last Doctolib valuation

$4.2B

Secondary · Apr 2026

Last Doctolib funding round

Strategic investment

Amount undisclosed · Oct 2026

Doctolib revenue

$430M

Strategic investment · Oct 2026

Key investors in Doctolib

  • Bpifrance
  • Kerala Ventures
  • Accel
  • Eurazeo
  • Pierre Kosciusko-Morizet
  • Bertrand Jelensperger

Doctolib Overview

About Doctolib

Doctolib is a healthcare technology company that runs an online platform on which patients book appointments with doctors, dentists, nurses and other practitioners, and sells practice-management software to those practitioners. Its subscription product covers agenda and patient management, electronic patient records, video consultation, secure messaging and tools for hospitals and clinics, while patients use the service free of charge. The company earns most of its revenue from monthly subscriptions paid by healthcare professionals and from software sold to health facilities. Doctolib was founded in 2013 by Stanislas Niox-Chateau and partners and is headquartered in Paris. It operates in France, Germany and Italy and entered the United Kingdom through an acquisition. It has grown partly through acquisitions of booking, communication and artificial intelligence businesses, and it develops clinical assistant tools based on language models.


Founded

2013

HQ

FranceParis

Status

Privately held

Customer focus

B2B & B2C

Revenue model

Commission, Subscription

Revenue

$430M (Oct 2026)

Valuation

$4.2B (Apr 2026)

Doctolib Valuation

Doctolib is currently valued at $4.2B, based on its secondary sale in April 2026. Read the announcement ↗

The $348M round included Invus, ATHOS KG, Generation Investment Management, Salica Investments and A.P. Moller Holding.

Doctolib's valuation has grown 3.8x from $1.1B at its Series E in March 2019 to $4.2B in April 2026, across 3 priced rounds.

Doctolib valuation by funding round

Doctolib valuation by funding round
DateStageValuation
Apr 2026Secondary$4.2B
Mar 2022Series F$6.4B
Mar 2019Series E$1.1B

Doctolib Revenue

Doctolib's latest recorded revenue is $430M, as of its strategic investment round in October 2026.

Doctolib revenue by funding round

Doctolib revenue and valuation multiple by funding round
DateRevenue *Stage
Oct 2026$430MStrategic investment

* Revenue (or ARR) figures are the values recorded alongside each funding round. Typically run-rate revenue at the time of the deal, or a reported LTM (last 12 months) revenue.

Doctolib Funding History

Doctolib has raised a total of $818M across 8 funding rounds, plus 1 secondary share sale.

Doctolib's first fundraising round was a $1M seed round in February 2014. The most recent completed round was a strategic investment round in October 2026.

Doctolib funding rounds

Doctolib funding rounds
DateStageInvestorsRaisedValuationDeal Summary
Oct 2026Strategic investmentNVIDIA (lead)--NVIDIA agreed on 13 October 2026 to buy a minority stake in Doctolib, the French healthcare platform said on the day, as part of planned investments in four French startups that also included Entalpic, Genesis AI and Pigment. Doctolib said NVIDIA's presence would help it develop artificial intelligence tools, and the company said it plans to build on open models while keeping health data in the EU and UK. NVIDIA described Doctolib as a European healthcare technology company that builds agents to free up healthcare professionals to deliver better care. NVIDIA said it has committed nearly USD 10 billion to the European technology ecosystem. Doctolib was founded in 2013 by Stanislas Niox-Chateau and is headquartered in Levallois-Perret, near Paris. It said 100 million patients and 580,000 health professionals now use its services. Its last disclosed primary valuation was EUR 5.8 billion, set in a 2022 funding round.
Apr 2026SecondaryInvus; ATHOS KG; Generation Investment Management; Salica Investments; A.P. Moller Holding$348M$4.2BEmployees and early investors in Doctolib sold shares worth just under EUR 300 million in a secondary transaction announced in April 2026, and new investors bought into the company's capital. Bloomberg reported the sale at about EUR 300 million (USD 345 million). The transaction valued Doctolib at EUR 3.6 billion, against EUR 5.8 billion at its last primary round in 2022. Buyers named in the press include Generation Investment Management, A.P. Moller Holding and ATHOS KG alongside existing shareholders. Doctolib reported annual recurring revenue of EUR 422 million for 2025, growth of more than 30 percent. Doctolib is a Paris-based healthcare technology company founded in 2013 by Stanislas Niox-Chateau. It sells appointment-booking and practice-management software to doctors and hospitals across France, Germany, Italy and other European markets, with patients using the service free of charge. The company is profitable on a recurring basis and has been named as a possible IPO candidate.
Mar 2022Series FEurazeo (lead); General Atlantic; Bpifrance$554M$6.4BDoctolib is a French healthcare technology platform that provides an online booking system for patient doctor appointments alongside a comprehensive suite of tools for healthcare practitioners, including patient management systems, teleconsultation services, and clinical note-taking capabilities. In March 2022, the company closed a Series F funding round at a post-money valuation of $6.4 billion, securing $549 million in combined equity and debt financing from investors including Eurazeo, Bpifrance, and General Atlantic. At the time of the 2022 round, the company was serving nearly 300,000 healthcare workers across Europe and was working with 250 public hospitals, though specific revenue figures for that period were not publicly disclosed. Doctolib subsequently achieved significant financial milestones, reaching €348 million in annual recurring revenue (ARR) by 2024, representing 22.5% year-over-year growth, with 99% of revenue derived from subscriptions paid by healthcare practitioners. The company has prioritized reinvestment in research and development, particularly in clinical artificial intelligence applications, spending €115 million on R&D in 2024 while working toward profitability, and as of early 2025 was positioned as France's most highly-valued VC-backed company alongside Mistral AI at €5.8 billion valuation.
Mar 2019Series EGeneral Atlantic (lead); Kernel Investissements; Bpifrance; Eurazeo; Accel$168M$1.1BDoctolib is a French healthtech company founded in 2013 that provides an online platform for booking doctor appointments, electronic health records (EHR), telemedicine, and management tools for healthcare practitioners across Europe, including France, Germany, Italy, Spain, Belgium, Netherlands, Portugal, Switzerland, Austria, and Luxembourg. It monetizes primarily through SaaS subscriptions paid by doctors, such as €139/month for patient booking (Doctolib Patient), €1.6K/year for EHR (Doctolib Médecin), and additional fees for telemedicine and card readers, with patients using the service for free. The company reached unicorn status with a €150 million Series D round in March 2019 led by General Atlantic, involving investors like Accel, Bpifrance, Eurazeo, and Kernel Investissements, marking its first major valuation milestone after six years. In March 2022, it raised $549 million in equity and debt from General Atlantic and Eurazeo at a $6.4 billion valuation. Doctolib has shown steady growth, reporting €348 million ARR in 2024 (up 22.5% from 2023), with 99% from practitioner subscriptions, France at 80% (~€278M), Germany ~20%, and accelerated new ARR growth of 42% in H2 2024. It serves 80 million patients and 400,000 healthcare professionals but remains pre-profitability, with 2024 losses at €53.8 million (down 38% from €87.1M in 2023) due to heavy R&D investment (€115M in 2024, ~one-third of revenue on AI and innovation), planning profitability in 2025. Competitively, Doctolib holds a dominant position in France (over 50-90% of online appointments, 40% of teleconsultations) but faces peers like Cegedim (€654.5M revenue 2024) and CompuGroup Medical (€1.15B revenue 2024). It recently received a €4.665M fine from French authorities for anti-competitive clauses in practitioner contracts until 2023, which it is appealing, following a 2019 complaint. The company has disclosed financials publicly for the first time ahead of a potential IPO, emphasizing transparency and long-term strategy.
Nov 2017Series DEurazeo (lead); Bpifrance$42M-Bpifrance and Eurazeo invested EUR 35 million in Doctolib in November 2017, in a round announced on 28 November 2017. Reuters reported that the amount was split about equally between Bpifrance, already a shareholder, and Eurazeo. The round followed a EUR 26 million raise in January 2017, bringing the total raised in 2017 to EUR 61 million and the total since creation to EUR 85 million. Bpifrance described it as the largest e-health fundraising of the year in Europe. The proceeds were intended to finance expansion in France and Germany, including about 200 additional hires in 2018 and an engineering centre in Germany. Doctolib is a Paris-based online medical appointment booking service and appointment-management software provider for healthcare professionals and facilities, launched in 2013 and co-founded by Stanislas Niox-Chateau. At the time of the round it served about 30,000 healthcare professionals and 800 healthcare facilities, was used by more than 12 million patients a month in France and Germany, and employed 380 people. Earlier investors included Accel and Kerala Ventures.
Jan 2017Series CBpifrance (lead); Kerala Ventures; Ludwig Klitzsch; Pierre Kosciusko-Morizet; Accel; Nicolas Brusson$28M-Doctolib is a French healthcare platform offering online appointment booking, management software, video consultations, and digital prescriptions, operating primarily in France and Germany as of 2017. The company was founded in 2013 and had expanded to Germany by early 2017. In January 2017, Doctolib announced a funding round led by Bpifrance, with participation from investors including Accel, Kerala Ventures, Ludwig Klitzsch, Nicolas Brusson, and Pierre Kosciusko-Morizet. A follow-on round in November 2017 raised $42 million (€35 million) from Eurazeo and Bpifrance, bringing total 2017 funding to approximately $72.7 million (€61 million). At the time of the 2017 rounds, Doctolib had significant traction with 30,000 health professionals using the platform across France and Germany, managing 1.5 million bookings in Germany alone, and attracting 12 million monthly visitors. The company employed around 380 people and charged practitioners €109 per month in France and €129 in Germany for its SaaS service, replacing traditional booking systems. Plans included hiring 100 employees each in France and Germany to solidify leadership in both markets. Later rounds included a March 2019 Series E led by General Atlantic at over $1.1 billion valuation and a March 2022 round reaching $6.4 billion. Doctolib continued growth, partnering with hospitals and expanding services.
Oct 2015Series BAccel (lead); Kerala Ventures; Bertrand Jelensperger; Pierre Kosciusko-Morizet; Nicolas Brusson$20M-Doctolib, a Paris-based startup founded in 2013, raised an €18 million ($20 million) Series B funding round on October 13, 2015, led by Accel Partners with participation from angels including Bertrand Jelensperger (LaFourchette co-founder), Pierre Kosciusko-Morizet (PriceMinister founder), and Nicolas Brusson (BlaBlaCar co-founder). This brought total funding to €23 million after a prior €5 million round. The company provides a SaaS platform for medical appointment booking, management, and patient reminders, reducing no-shows by up to 75% and helping doctors acquire up to 20 new patients monthly. By late 2015, it had signed up over 5,000 doctors and 100 clinics across 80 specialisms in France, serving two million patients monthly, with 15 regional offices. The subscription-based service targets individual physicians to large hospitals, enabling real-time availability checks, online bookings, and compliance with French health data laws. Doctolib positioned itself in a market of 8 billion annual European medical appointments, aiming to expand internationally from its French base to become Europe's top doctor booking platform. Funds were allocated to growth in France and entry into new European countries, competing with DocPlanner, Zesty, and KelDoc. Later rounds included a €26 million raise in 2017 with Accel and Bpifrance (total ~€50 million), a €150 million Series E in 2019 at over €1 billion valuation led by General Atlantic, and further growth to $6.4 billion by 2022.
Nov 2014Series AKerala Ventures (lead); Bertrand Jelensperger; Pierre Kosciusko-Morizet$5M-Doctolib raised EUR 4 million in November 2014 from its existing investors and new business angels, including Pierre Kosciusko-Morizet, co-founder of PriceMinister. The round followed a EUR 1 million seed round in February 2014 and was the company's second financing. Bertrand Jelensperger and the founders' vehicle Kerala Ventures were among the earlier backers. Management said it wanted to become the Google of health, using the money to hire engineers and sales staff and to extend coverage of practitioners across France. Doctolib, founded in 2013 and based in Paris, provides an online platform on which patients book medical appointments and a subscription software tool that practitioners use to manage their agendas. The company later raised a USD 20 million Series B in October 2015 led by Accel.
Feb 2014SeedKerala Ventures (lead); Olivier Occelli; Antoine Freysz; Bertrand Jelensperger$1M-Doctolib raised a seed round of EUR 1 million in February 2014 from business angels, among them Bertrand Jelensperger, co-founder of LaFourchette. The round was Doctolib's first outside funding, a year after the company was founded in 2013 in Paris by Stanislas Niox-Chateau and partners. Kerala Ventures, the investment vehicle of the founding team, had backed the company from its creation. Doctolib operates an online platform on which patients book appointments with doctors and which sells appointment-management software to practitioners on a subscription basis. The seed money was meant to extend the product to more practitioners and to build the team. At the time of the announcement the company was a young Paris start-up with a small team and a few hundred practitioners signed up.

Who has invested in Doctolib?

18 investors have backed Doctolib across its funding rounds, including Bpifrance, Kerala Ventures, Accel, Eurazeo, Pierre Kosciusko-Morizet and Bertrand Jelensperger.

Lead investors include NVIDIA, Eurazeo, General Atlantic, Bpifrance, Accel and 1 other investor.


Doctolib Investors

Investors in Doctolib by funding rounds participated
InvestorHQRoundsRoleFirst check
Kerala VenturesFranceParis4LeadFeb 2014
BpifranceFranceParis4LeadJan 2017
Bertrand JelenspergerFranceParis3ParticipantFeb 2014
EurazeoFranceParis3LeadNov 2017
Pierre Kosciusko-MorizetFranceParis3ParticipantNov 2014
AccelUnited StatesPalo Alto, CA3LeadOct 2015
General AtlanticUnited StatesNew York City, NY2LeadMar 2019
Nicolas BrussonUnited KingdomLondon2ParticipantOct 2015
NVIDIAUnited StatesSanta Clara, CA1LeadOct 2026
Olivier OccelliFranceParis1ParticipantFeb 2014
Antoine FreyszFranceParis1ParticipantFeb 2014
InvusUnited StatesNew York City, NY1ParticipantApr 2026
Ludwig KlitzschGermanyMunich1ParticipantJan 2017

This data is available for Pro users. Sign up to see all 18 Doctolib investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Acquisitions by Doctolib

Doctolib has acquired 7 companies to date.

Last acquisition by Doctolib was on May 4th 2026. Doctolib acquired Medicus Health for undisclosed valuation.


Latest Acquisitions by Doctolib

Medicus Health
Typeless
Aaron.ai
Siilo
Description
Medicus Health is a patient record system for general practitioners delivering primary care. The platform addresses clinician and patient requirements through its design.
Typeless is a Swiss platform developing digital tools to streamline information exchange for healthcare carers and patients. Based in Zurich, it provides secure messaging, task assignment, and documentation systems tailored for home care services across Europe. Typeless emphasizes data privacy under EU regulations, supporting multilingual interfaces for nursing teams managing chronic care and elderly support.
Aaron.ai is a Berlin-headquartered SaaS provider of conversational AI phone assistants for doctors, automating administrative tasks like appointment scheduling and patient triage. The platform supports German-speaking healthcare providers, including partnerships with the Federal Ministry of Health and National Medical Association for pandemic response efforts.
Siilo is an Amsterdam-headquartered secure messaging platform for healthcare professionals across Europe. Founded in 2016, it offers encrypted chat, video calls, and file sharing compliant with GDPR and HIPAA standards. The app streamlines clinical workflows for multidisciplinary teams in hospitals and clinics, with adoption in the Netherlands, Belgium, and the United Kingdom.
HQ CountryUnited KingdomSwitzerlandGermanyNetherlands
HQ City
London
Lausanne
-
Amsterdam
Deal Date4 May 202621 Jun 202422 May 20242 Mar 2023
Valuationundisclosedundisclosed$43Mundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Doctolib acquisitions and their M&A valuation multiples.

Start Free Trial

Doctolib Competitors

Doctolib competitors include listed companies like B-Soft Co. and Phreesia, and private ones like Abridge, Cityblock Health, Grow Therapy and Commure.

Public and private companies comparable to Doctolib
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
AbridgeUnited StatesPittsburgh, PAPrivate$117M-$5.3B45.3x
Cityblock HealthUnited StatesNew York City, NYPrivate$2.2B-$5.7B-
Grow TherapyUnited StatesNew York City, NYPrivate$1B-$3B-
CommureUnited StatesSan Francisco, CAPrivate$200M-$7B35.0x
B-Soft Co.ChinaChinaPublicly listed$158M($37M)$802M5.1x
PhreesiaUnited StatesUnited StatesPublicly listed$481M$27M$783M1.5x

Doctolib Public Comps

Doctolib is still privately-owned, but its public comps include CCC Intelligent Solutions, Life360, Privia Health, Waystar, Strive, Doximity, Meitu, Grindr, Hims and Tieto.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
CCC Intelligent Solutions$1.1B$238M4.3x4.0x19.1x9.4x
Life360$489M$32M7.6x5.7x114.9x29.0x
Privia Health$2.1B$44M1.3x1.1x62.1x18.2x
Waystar$1.1B$390M6.1x5.3x17.1x12.5x
Strive$4M($21M)989.0x339.3x(168.8x)(65.9x)
Doximity$645M$229M7.9x7.7x22.3x15.1x
Meitu$579M$138M3.6x3.0x15.1x11.1x
Grindr$440M$145M6.2x5.0x18.9x11.9x

This data is available for Pro users. Sign up to see all Doctolib competitors and their valuation data.

Start Free Trial

Common questions about Doctolib

When was Doctolib founded?Doctolib was founded in 2013.
Where is Doctolib headquartered?Doctolib is headquartered in Paris, France.
Is Doctolib publicly listed?No, Doctolib is a private, VC-backed company.
What is Doctolib's valuation?Doctolib was last valued at $4.2B in its secondary sale in April 2026.
How much funding has Doctolib raised?Doctolib has raised $818M across 8 funding rounds.
What was Doctolib's last funding round?Doctolib's last funding round was a strategic investment round in October 2026, led by NVIDIA.
Who are Doctolib's investors?Doctolib's investors include Kerala Ventures, Bpifrance, Bertrand Jelensperger, Eurazeo, Pierre Kosciusko-Morizet, Accel, General Atlantic, Nicolas Brusson, NVIDIA, Olivier Occelli and 8 others.
What is Doctolib's revenue?Doctolib's latest recorded revenue is $430M (October 2026).
Which companies are comparable to Doctolib?Companies comparable to Doctolib include Abridge, Cityblock Health, Grow Therapy, Commure, B-Soft Co. and Phreesia.
How many companies has Doctolib acquired?Doctolib has acquired 7 companies, including Medicus Health, Typeless, Aaron.ai, Siilo and Tanker.
What was the largest acquisition by Doctolib?The $70M acquisition of Mondocteur.fr in July 2018 is the largest acquisition Doctolib has made to date.

See companies similar to Doctolib

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial